APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Recombinant Antibody Production Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Recombinant Antibody Production Service Market Outlook and Growth Opportunities 2026

12 August 2026203 pages

Choose your research edition.

Industry ResearchCustom Recombinant Antibody Production Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Recombinant Antibody Production Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Custom Recombinant Antibody Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Recombinant Antibody Production Service Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Recombinant Antibody Production Service Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

The global Custom Recombinant Antibody Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Recombinant Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Recombinant Antibody Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Recombinant Antibody Production Service market include RayBiotech, Cygnus Technologies, Cayman Chemical, Boster Bio, Bon Opus Biosciences, Biomatik, Abcam, Bio-Rad and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Recombinant Antibody Production Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Recombinant Antibody Production Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Recombinant Antibody Production Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Recombinant Antibody Production Service market.

Custom Recombinant Antibody Production Service Segment by Company

RayBiotech

Cygnus Technologies

Cayman Chemical

Boster Bio

Bon Opus Biosciences

Biomatik

Abcam

Bio-Rad

Creative Biolabs

ProteoGenix

Sino Biological

Absolute Antibody

ProMab Biotechnologies

ACROBiosystems

Cusabio Technology

Covance

evitria

ProSci

GenScript

Custom Recombinant Antibody Production Service Segment by Type

Monoclonal Antibody (mAb) Production

Polyclonal Antibody (pAb) Production

Custom Recombinant Antibody Production Service Segment by Application

Pharmaceutics

Scientific Research

Others

Custom Recombinant Antibody Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Recombinant Antibody Production Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Recombinant Antibody Production Service key companies, revenue, market share, and recent developments.

3. To split the Custom Recombinant Antibody Production Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Recombinant Antibody Production Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Recombinant Antibody Production Service significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Recombinant Antibody Production Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Recombinant Antibody Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Recombinant Antibody Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Recombinant Antibody Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Recombinant Antibody Production Service industry.

Chapter 3: Detailed analysis of Custom Recombinant Antibody Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Recombinant Antibody Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Recombinant Antibody Production Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Recombinant Antibody Production Service Industry Trends Table 2. Custom Recombinant Antibody Production Service Industry Drivers Table 3. Custom Recombinant Antibody Production Service Industry Opportunities and Challenges Table 4. Custom Recombinant Antibody Production Service Industry Restraints Table 5. Global Custom Recombinant Antibody Production Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Recombinant Antibody Production Service Revenue Share by Company (2021-2026) Table 7. Global Custom Recombinant Antibody Production Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Recombinant Antibody Production Service Key Company Manufacturing Base & Headquarters Table 9. Global Custom Recombinant Antibody Production Service Company, Product Type & Application Table 10. Global Custom Recombinant Antibody Production Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Recombinant Antibody Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Monoclonal Antibody (mAb) Production Table 15. Significant Companies of Polyclonal Antibody (pAb) Production Table 16. Global Custom Recombinant Antibody Production Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Custom Recombinant Antibody Production Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Custom Recombinant Antibody Production Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Custom Recombinant Antibody Production Service Sales Value Share by Type (2021-2026) Table 20. Global Custom Recombinant Antibody Production Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutics Table 22. Significant Companies of Scientific Research Table 23. Significant Companies of Others Table 24. Global Custom Recombinant Antibody Production Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Custom Recombinant Antibody Production Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Custom Recombinant Antibody Production Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Custom Recombinant Antibody Production Service Sales Value Share by Application (2021-2026) Table 28. Global Custom Recombinant Antibody Production Service Sales Value Share by Application (2027-2032) Table 29. Global Custom Recombinant Antibody Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Custom Recombinant Antibody Production Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Custom Recombinant Antibody Production Service Sales Value Share by Region (2021-2026) Table 32. Global Custom Recombinant Antibody Production Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Custom Recombinant Antibody Production Service Sales Value Share by Region (2027-2032) Table 34. Global Custom Recombinant Antibody Production Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Custom Recombinant Antibody Production Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Custom Recombinant Antibody Production Service Sales Value Market Share by Country (2021-2026) Table 37. Global Custom Recombinant Antibody Production Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Custom Recombinant Antibody Production Service Sales Value Market Share by Country (2027-2032) Table 39. RayBiotech Company Information Table 40. RayBiotech Business Overview Table 41. RayBiotech Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. RayBiotech Custom Recombinant Antibody Production Service Product Portfolio Table 43. RayBiotech Recent Development Table 44. Cygnus Technologies Company Information Table 45. Cygnus Technologies Business Overview Table 46. Cygnus Technologies Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Cygnus Technologies Custom Recombinant Antibody Production Service Product Portfolio Table 48. Cygnus Technologies Recent Development Table 49. Cayman Chemical Company Information Table 50. Cayman Chemical Business Overview Table 51. Cayman Chemical Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Cayman Chemical Custom Recombinant Antibody Production Service Product Portfolio Table 53. Cayman Chemical Recent Development Table 54. Boster Bio Company Information Table 55. Boster Bio Business Overview Table 56. Boster Bio Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Boster Bio Custom Recombinant Antibody Production Service Product Portfolio Table 58. Boster Bio Recent Development Table 59. Bon Opus Biosciences Company Information Table 60. Bon Opus Biosciences Business Overview Table 61. Bon Opus Biosciences Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bon Opus Biosciences Custom Recombinant Antibody Production Service Product Portfolio Table 63. Bon Opus Biosciences Recent Development Table 64. Biomatik Company Information Table 65. Biomatik Business Overview Table 66. Biomatik Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Biomatik Custom Recombinant Antibody Production Service Product Portfolio Table 68. Biomatik Recent Development Table 69. Abcam Company Information Table 70. Abcam Business Overview Table 71. Abcam Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Abcam Custom Recombinant Antibody Production Service Product Portfolio Table 73. Abcam Recent Development Table 74. Bio-Rad Company Information Table 75. Bio-Rad Business Overview Table 76. Bio-Rad Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bio-Rad Custom Recombinant Antibody Production Service Product Portfolio Table 78. Bio-Rad Recent Development Table 79. Creative Biolabs Company Information Table 80. Creative Biolabs Business Overview Table 81. Creative Biolabs Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Creative Biolabs Custom Recombinant Antibody Production Service Product Portfolio Table 83. Creative Biolabs Recent Development Table 84. ProteoGenix Company Information Table 85. ProteoGenix Business Overview Table 86. ProteoGenix Custom Recombinant Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ProteoGenix Custom Recombinant Antibody Production Service Product Portfolio Table 88. ProteoGenix Recent Development Table 89. Sino Biological Company Information Table 90. Sino Biological Business Overview Table 91. Sino Biological Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sino Biological Custom Recombinant Antibody Production Service Product Portfolio Table 93. Sino Biological Recent Development Table 94. Absolute Antibody Company Information Table 95. Absolute Antibody Business Overview Table 96. Absolute Antibody Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Absolute Antibody Custom Recombinant Antibody Production Service Product Portfolio Table 98. Absolute Antibody Recent Development Table 99. ProMab Biotechnologies Company Information Table 100. ProMab Biotechnologies Business Overview Table 101. ProMab Biotechnologies Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. ProMab Biotechnologies Custom Recombinant Antibody Production Service Product Portfolio Table 103. ProMab Biotechnologies Recent Development Table 104. ACROBiosystems Company Information Table 105. ACROBiosystems Business Overview Table 106. ACROBiosystems Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. ACROBiosystems Custom Recombinant Antibody Production Service Product Portfolio Table 108. ACROBiosystems Recent Development Table 109. Cusabio Technology Company Information Table 110. Cusabio Technology Business Overview Table 111. Cusabio Technology Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Cusabio Technology Custom Recombinant Antibody Production Service Product Portfolio Table 113. Cusabio Technology Recent Development Table 114. Covance Company Information Table 115. Covance Business Overview Table 116. Covance Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Covance Custom Recombinant Antibody Production Service Product Portfolio Table 118. Covance Recent Development Table 119. evitria Company Information Table 120. evitria Business Overview Table 121. evitria Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. evitria Custom Recombinant Antibody Production Service Product Portfolio Table 123. evitria Recent Development Table 124. ProSci Company Information Table 125. ProSci Business Overview Table 126. ProSci Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. ProSci Custom Recombinant Antibody Production Service Product Portfolio Table 128. ProSci Recent Development Table 129. GenScript Company Information Table 130. GenScript Business Overview Table 131. GenScript Custom Recombinant Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. GenScript Custom Recombinant Antibody Production Service Product Portfolio Table 133. GenScript Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Custom Recombinant Antibody Production Service Product Image Figure 2. Global Custom Recombinant Antibody Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Recombinant Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Recombinant Antibody Production Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Monoclonal Antibody (mAb) Production Image Figure 8. Polyclonal Antibody (pAb) Production Image Figure 9. Global Custom Recombinant Antibody Production Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Custom Recombinant Antibody Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Custom Recombinant Antibody Production Service Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutics Image Figure 13. Scientific Research Image Figure 14. Others Image Figure 15. Global Custom Recombinant Antibody Production Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Custom Recombinant Antibody Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Custom Recombinant Antibody Production Service Sales Value Share by Application (2021-2032) Figure 18. Global Custom Recombinant Antibody Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Custom Recombinant Antibody Production Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Custom Recombinant Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Custom Recombinant Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Custom Recombinant Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Custom Recombinant Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Custom Recombinant Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Custom Recombinant Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Custom Recombinant Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Custom Recombinant Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Custom Recombinant Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Custom Recombinant Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibody (mAb) Production
  • Polyclonal Antibody (pAb) Production
Applications
  • Pharmaceutics
  • Scientific Research
  • Others
Companies covered
  • RayBiotech
  • Cygnus Technologies
  • Cayman Chemical
  • Boster Bio
  • Bon Opus Biosciences
  • Biomatik
  • Abcam
  • Bio-Rad
  • Creative Biolabs
  • ProteoGenix
  • Sino Biological
  • Absolute Antibody
  • ProMab Biotechnologies
  • ACROBiosystems
  • Cusabio Technology
  • Covance
  • evitria
  • ProSci
  • GenScript

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Recombinant Antibody Production Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Recombinant Antibody Production Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Recombinant Antibody Production Service Market Dynamics
  1. 2.1 Custom Recombinant Antibody Production Service Industry Trends
  2. 2.2 Custom Recombinant Antibody Production Service Industry Drivers
  3. 2.3 Custom Recombinant Antibody Production Service Industry Opportunities and Challenges
  4. 2.4 Custom Recombinant Antibody Production Service Industry Restraints
3 Custom Recombinant Antibody Production Service Market by Company
  1. 3.1 Global Custom Recombinant Antibody Production Service Company Revenue Ranking in 2025
  2. 3.2 Global Custom Recombinant Antibody Production Service Revenue by Company (2021-2026)
  3. 3.3 Global Custom Recombinant Antibody Production Service Company Ranking (2024-2026)
  4. 3.4 Global Custom Recombinant Antibody Production Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Recombinant Antibody Production Service Company Product Type and Application
  6. 3.6 Global Custom Recombinant Antibody Production Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Recombinant Antibody Production Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Recombinant Antibody Production Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Recombinant Antibody Production Service Market by Type
  1. 4.1 Custom Recombinant Antibody Production Service Type Introduction
  2. 4.1.1 Monoclonal Antibody (mAb) Production
  3. 4.1.2 Polyclonal Antibody (pAb) Production
  4. 4.2 Global Custom Recombinant Antibody Production Service Sales Value by Type
  5. 4.2.1 Global Custom Recombinant Antibody Production Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Custom Recombinant Antibody Production Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Custom Recombinant Antibody Production Service Sales Value Share by Type (2021-2032)
5 Custom Recombinant Antibody Production Service Market by Application
  1. 5.1 Custom Recombinant Antibody Production Service Application Introduction
  2. 5.1.1 Pharmaceutics
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Custom Recombinant Antibody Production Service Sales Value by Application
  6. 5.2.1 Global Custom Recombinant Antibody Production Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Custom Recombinant Antibody Production Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Custom Recombinant Antibody Production Service Sales Value Share by Application (2021-2032)
6 Custom Recombinant Antibody Production Service Regional Value Analysis
  1. 6.1 Global Custom Recombinant Antibody Production Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Recombinant Antibody Production Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Recombinant Antibody Production Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Recombinant Antibody Production Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Recombinant Antibody Production Service Sales Value (2021-2032)
  7. 6.3.2 North America Custom Recombinant Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Recombinant Antibody Production Service Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Recombinant Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Recombinant Antibody Production Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Recombinant Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Recombinant Antibody Production Service Sales Value (2021-2032)
  16. 6.6.2 South America Custom Recombinant Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Recombinant Antibody Production Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Recombinant Antibody Production Service Sales Value Share by Country, 2025 VS 2032
7 Custom Recombinant Antibody Production Service Country-level Value Analysis
  1. 7.1 Global Custom Recombinant Antibody Production Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Recombinant Antibody Production Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Recombinant Antibody Production Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Recombinant Antibody Production Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Recombinant Antibody Production Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Recombinant Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Recombinant Antibody Production Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RayBiotech
  2. 8.1.1 RayBiotech Company Information
  3. 8.1.2 RayBiotech Business Overview
  4. 8.1.3 RayBiotech Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 RayBiotech Custom Recombinant Antibody Production Service Product Portfolio
  6. 8.1.5 RayBiotech Recent Developments
  7. 8.2 Cygnus Technologies
  8. 8.2.1 Cygnus Technologies Company Information
  9. 8.2.2 Cygnus Technologies Business Overview
  10. 8.2.3 Cygnus Technologies Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cygnus Technologies Custom Recombinant Antibody Production Service Product Portfolio
  12. 8.2.5 Cygnus Technologies Recent Developments
  13. 8.3 Cayman Chemical
  14. 8.3.1 Cayman Chemical Company Information
  15. 8.3.2 Cayman Chemical Business Overview
  16. 8.3.3 Cayman Chemical Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cayman Chemical Custom Recombinant Antibody Production Service Product Portfolio
  18. 8.3.5 Cayman Chemical Recent Developments
  19. 8.4 Boster Bio
  20. 8.4.1 Boster Bio Company Information
  21. 8.4.2 Boster Bio Business Overview
  22. 8.4.3 Boster Bio Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boster Bio Custom Recombinant Antibody Production Service Product Portfolio
  24. 8.4.5 Boster Bio Recent Developments
  25. 8.5 Bon Opus Biosciences
  26. 8.5.1 Bon Opus Biosciences Company Information
  27. 8.5.2 Bon Opus Biosciences Business Overview
  28. 8.5.3 Bon Opus Biosciences Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bon Opus Biosciences Custom Recombinant Antibody Production Service Product Portfolio
  30. 8.5.5 Bon Opus Biosciences Recent Developments
  31. 8.6 Biomatik
  32. 8.6.1 Biomatik Company Information
  33. 8.6.2 Biomatik Business Overview
  34. 8.6.3 Biomatik Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biomatik Custom Recombinant Antibody Production Service Product Portfolio
  36. 8.6.5 Biomatik Recent Developments
  37. 8.7 Abcam
  38. 8.7.1 Abcam Company Information
  39. 8.7.2 Abcam Business Overview
  40. 8.7.3 Abcam Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abcam Custom Recombinant Antibody Production Service Product Portfolio
  42. 8.7.5 Abcam Recent Developments
  43. 8.8 Bio-Rad
  44. 8.8.1 Bio-Rad Company Information
  45. 8.8.2 Bio-Rad Business Overview
  46. 8.8.3 Bio-Rad Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Custom Recombinant Antibody Production Service Product Portfolio
  48. 8.8.5 Bio-Rad Recent Developments
  49. 8.9 Creative Biolabs
  50. 8.9.1 Creative Biolabs Company Information
  51. 8.9.2 Creative Biolabs Business Overview
  52. 8.9.3 Creative Biolabs Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Creative Biolabs Custom Recombinant Antibody Production Service Product Portfolio
  54. 8.9.5 Creative Biolabs Recent Developments
  55. 8.10 ProteoGenix
  56. 8.10.1 ProteoGenix Company Information
  57. 8.10.2 ProteoGenix Business Overview
  58. 8.10.3 ProteoGenix Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ProteoGenix Custom Recombinant Antibody Production Service Product Portfolio
  60. 8.10.5 ProteoGenix Recent Developments
  61. 8.11 Sino Biological
  62. 8.11.1 Sino Biological Company Information
  63. 8.11.2 Sino Biological Business Overview
  64. 8.11.3 Sino Biological Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sino Biological Custom Recombinant Antibody Production Service Product Portfolio
  66. 8.11.5 Sino Biological Recent Developments
  67. 8.12 Absolute Antibody
  68. 8.12.1 Absolute Antibody Company Information
  69. 8.12.2 Absolute Antibody Business Overview
  70. 8.12.3 Absolute Antibody Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Absolute Antibody Custom Recombinant Antibody Production Service Product Portfolio
  72. 8.12.5 Absolute Antibody Recent Developments
  73. 8.13 ProMab Biotechnologies
  74. 8.13.1 ProMab Biotechnologies Company Information
  75. 8.13.2 ProMab Biotechnologies Business Overview
  76. 8.13.3 ProMab Biotechnologies Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ProMab Biotechnologies Custom Recombinant Antibody Production Service Product Portfolio
  78. 8.13.5 ProMab Biotechnologies Recent Developments
  79. 8.14 ACROBiosystems
  80. 8.14.1 ACROBiosystems Company Information
  81. 8.14.2 ACROBiosystems Business Overview
  82. 8.14.3 ACROBiosystems Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ACROBiosystems Custom Recombinant Antibody Production Service Product Portfolio
  84. 8.14.5 ACROBiosystems Recent Developments
  85. 8.15 Cusabio Technology
  86. 8.15.1 Cusabio Technology Company Information
  87. 8.15.2 Cusabio Technology Business Overview
  88. 8.15.3 Cusabio Technology Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cusabio Technology Custom Recombinant Antibody Production Service Product Portfolio
  90. 8.15.5 Cusabio Technology Recent Developments
  91. 8.16 Covance
  92. 8.16.1 Covance Company Information
  93. 8.16.2 Covance Business Overview
  94. 8.16.3 Covance Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Covance Custom Recombinant Antibody Production Service Product Portfolio
  96. 8.16.5 Covance Recent Developments
  97. 8.17 evitria
  98. 8.17.1 evitria Company Information
  99. 8.17.2 evitria Business Overview
  100. 8.17.3 evitria Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 evitria Custom Recombinant Antibody Production Service Product Portfolio
  102. 8.17.5 evitria Recent Developments
  103. 8.18 ProSci
  104. 8.18.1 ProSci Company Information
  105. 8.18.2 ProSci Business Overview
  106. 8.18.3 ProSci Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ProSci Custom Recombinant Antibody Production Service Product Portfolio
  108. 8.18.5 ProSci Recent Developments
  109. 8.19 GenScript
  110. 8.19.1 GenScript Company Information
  111. 8.19.2 GenScript Business Overview
  112. 8.19.3 GenScript Custom Recombinant Antibody Production Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 GenScript Custom Recombinant Antibody Production Service Product Portfolio
  114. 8.19.5 GenScript Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst